Articles Tagged With:
-
Ethical Response Needed if Surrogate Disregards Patients’ Wishes
The role of surrogate decision-makers is to make decisions consistent with the patient’s previously expressed wishes, written documents, and values. But that is not what usually happens. Lack of communication between the patient and the surrogate and/or between the surrogate and the medical team is the biggest obstacle.
-
Hospital Leaders Asking Questions About ‘Value’ of Clinical Ethics to Organization
Administrators expect to see evidence that a clinical ethical program is worth supporting with financial resources. Yet many ethicists are unprepared for this kind of conversation, one that requires data for an effective response.
-
Icosapent Ethyl Capsules (Vascepa)
Icosapent is the first drug approved to reduce the risk of cardiovascular events in patients with established cardiovascular disease and hypertriglyceridemia on maximally tolerated statin therapy.
-
CNS Agents Emerge as Frontrunners in FDA-Approved Treatments for Low Libido in Women
Low libido is the most common sexual complaint, affecting up to 38.7% of women, with up to 12.3% also reporting significant distress associated with this condition. Debate continues about how female desire disorders are characterized, diagnosed, and treated.
-
The Risk of Endocarditis With Bacteremia
Interrogation of the Danish National Patient Registry revealed bacteremia due to Enterococcus faecalis was most likely to be associated with infective endocarditis; thus, echocardiography is warranted in these patients.
-
Fever of Unknown Origin Due to Cat Scratch Disease
Disseminated cat scratch disease may present as a fever of unknown origin.
-
Longer Antibiotic Courses for Pneumonia Do Not Improve Outcomes, Do Cause More Adverse Effects
Excess antibiotic therapy did not improve mortality or morbidity outcomes, although each additional antibiotic day was associated with 3% increased odds of antibiotic-associated adverse drug events.
-
WHO International Emergency: A Great Wall Around China?
The World Health Organization (WHO) declared the 2019-nCoV outbreak in China a Public Health Emergency of International Concern (PHEIC) on Jan. 30, 2020. In doing so, WHO emphasized that China should not be isolated from the global community, which can happen after a PHEIC is issued.
-
Assessing 2019-nCoV Risk to Healthcare Workers
In one of the first reports of the clear risk of 2019 novel coronavirus (2019-nCoV) to healthcare workers, an outbreak in a hospital in Wuhan, China, resulted in 40 infections in clinical staff caring for patients.
-
Two U.S. Cases of Person-to-Person Transmission, More Expected
As of Feb. 13, 2020, there were 15 cases of the new coronavirus in the United States, with 13 of them infected travelers returning from Wuhan, China. There is concern that the community spread could continue, even as travel from China is being checked aggressively.